Metabonomic investigation of liver profiles of nonpolar metabolites obtained from alcohol-dosed rats and mice using high mass accuracy MSn analysis.

Alcoholism is a complex disorder that, in man, appears to be genetically influenced, although the underlying genes and molecular pathways are not completely known. Here, the intragastric alcohol feeding model in rodents was used together with high mass accuracy LC-MS(n) analysis to assess the metabonomic changes in nonpolar metabolite profiles for livers from control and alcohol-treated rats and mice. Ion signals with a peak area variance of less than 30% (based on repeat analysis of a pooled quality control sample analyzed throughout the batch) were submitted to multivariate statistical analysis (using principal components analysis, PCA). PCA revealed robust differences between profiles from control and alcohol-treated animals from both species. The major metabolites seen to differ between control and alcohol-treated animals were identified using high accuracy MS(n) data and verified using external search engines ( http://www.lipidmaps.org ; http://www.hmdb.ca; http://www.genome.jp/kegg/ ) and authentic standards. The main metabolite classes to show major changes in the alcoholic liver-derived samples were fatty acyls, fatty acid ethyl esters, glycerolipids, and phosphatidylethanol homologues. Significant metabolites that were up-regulated by alcohol treatment in both rat and mouse livers included fatty acyls, metabolites such as octadecatrienoic acid and eicosapentaenoic acid, a number of fatty acid ethyl esters such as ethyl arachidonate, ethyl docosahexaenoic acid, ethyl linoleate, and ethyl oleate and phosphatidylethanol (PEth) homologues (predominantly PEth 18:0/18:2 and PEth 16:0/18:2; PEth homologues are currently considered as potential biomarkers for harmful and prolonged alcohol consumption in man). A number of glycerophospholipids resulted in both up-regulation (m/z 903.7436 [M + H](+) corresponding to a triglyceride) and down-regulation (m/z 667.5296 [M + H](+) corresponding to a diglyceride). Metabolite profiles were broadly similar in both mouse and rat models. However, there were a number of significant differences in the alcohol-treated group particularly in the marked down-regulation of retinol and free cholesterol in the mouse compared to the rat. Unique markers for alcohol treatment included ethyl docosahexaenoic acid. Metabolites were identified with high confidence using predominantly negative ion MS(n) data for the fatty acyl components to match to www.lipidmaps.org MS and MS/MS databases; interpreting positive ion data needed to take into account possible adduct ions which may confound the identification of other lipid classes. The observed changes in lipid profiles were consistent with alcohol-induced liver injury in humans.

[1]  J. Lindon,et al.  Metabonomics: a platform for studying drug toxicity and gene function , 2002, Nature Reviews Drug Discovery.

[2]  Yufang Zheng,et al.  Molecular species of the alcohol biomarker phosphatidylethanol in human blood measured by LC-MS. , 2009, Clinical chemistry.

[3]  N. Kaplowitz,et al.  Differences in betaine‐homocysteine methyltransferase expression, endoplasmic reticulum stress response, and liver injury between alcohol‐fed mice and rats , 2010, Hepatology.

[4]  I. Rusyn,et al.  Metabolomic profiling of a modified alcohol liquid diet model for liver injury in the mouse uncovers new markers of disease. , 2008, Toxicology and applied pharmacology.

[5]  O. Fiehn Metabolomics – the link between genotypes and phenotypes , 2004, Plant Molecular Biology.

[6]  Ian D Wilson,et al.  Analytical strategies in metabonomics. , 2007, Journal of proteome research.

[7]  F. Wurst,et al.  Ethyl sulphate: a direct ethanol metabolite reflecting recent alcohol consumption. , 2006, Addiction.

[8]  H. Tsukamoto,et al.  Insights into the pathogenesis of alcoholic liver necrosis and fibrosis: Status report , 1990, Hepatology.

[9]  H. Tsukamoto,et al.  Intragastric ethanol infusion model in rodents. , 2008, Methods in molecular biology.

[10]  H. Tsukamoto,et al.  Long-term cannulation model for blood sampling and intragastric infusion in the rat. , 1984, The American journal of physiology.

[11]  Vinod P. Shah,et al.  Quantitative Bioanalytical Methods Validation and Implementation: Best Practices for Chromatographic and Ligand Binding Assays , 2007 .

[12]  Qian Yang,et al.  Identification of noninvasive biomarkers for alcohol-induced liver disease using urinary metabolomics and the Ppara-null mouse. , 2010, Journal of proteome research.

[13]  M. Laposata Fatty acid ethyl esters: nonoxidative metabolites of ethanol , 1998, Addiction biology.

[14]  I. Wilson,et al.  LC-MS-based methodology for global metabolite profiling in metabonomics/metabolomics , 2008 .

[15]  I. Wilson,et al.  Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine. , 2007, Journal of proteome research.

[16]  I. Wilson,et al.  An NMR‐based metabonomic approach to investigate the biochemical consequences of genetic strain differences: application to the C57BL10J and Alpk:ApfCD mouse , 2000, FEBS letters.

[17]  I. Wilson,et al.  Evaluation of the repeatability of ultra-performance liquid chromatography-TOF-MS for global metabolic profiling of human urine samples. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[18]  E. Want,et al.  Global metabolic profiling procedures for urine using UPLC–MS , 2010, Nature Protocols.

[19]  Guowang Xu,et al.  The Application of Chromatography-Mass Spectrometry: Methods to Metabonomics , 2009 .

[20]  J. Lindon,et al.  'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[21]  F. Crews,et al.  1H NMR-based metabolomic analysis of liver, serum, and brain following ethanol administration in rats. , 2008, Chemical research in toxicology.

[22]  L. Gustavsson ESBRA 1994 Award Lecture. Phosphatidylethanol formation: specific effects of ethanol mediated via phospholipase D. , 1995, Alcohol and alcoholism.

[23]  F. Wurst,et al.  Ethyl glucuronide--a marker of alcohol consumption and a relapse marker with clinical and forensic implications. , 1999, Alcohol and alcoholism.